{"text": ["CORRECTED-UPDATE", "2-AstraZeneca,", "Pfizer", "vaccines", "effective", "against", "Delta", "COVID-19", "variants-study"], "created_at": "2021-06-22 18:53:33"}
{"text": ["Less", "Turbulence", "Ahead", "for", "Spirit", "AeroSystems"], "created_at": "2021-06-22 14:47:34"}
{"text": ["BioNTech", "to", "look", "into", "possible", "dividend", "next", "year"], "created_at": "2021-06-22 13:08:13"}
{"text": ["Switzerland", "recommends", "12-15", "year", "olds", "get", "Pfizer/BioNTech", "COVID-19", "shot"], "created_at": "2021-06-22 13:07:07"}
{"text": ["New", "research", "says", "Pfizer", "and", "Moderna's", "mRNA", "vaccines", "don't", "affect", "sperm", "parameters"], "created_at": "2021-06-22 12:40:30"}
{"text": ["CDC", "committee", "to", "discuss", "rare", "cases", "of", "myocarditis", "occurring", "in", "people", "who", "have", "gotten", "their", "COVID-19", "shots"], "created_at": "2021-06-22 12:14:01"}
{"text": ["GSK-", "Pfizer's", "ViiV", "To", "Develop", "'Ultra-Long-Acting'", "HIV", "Drugs", "With", "$215M", "Halozyme", "Deal"], "created_at": "2021-06-22 10:29:34"}
{"text": ["ViiV", "Healthcare", "and", "Halozyme", "enter", "global", "collaboration", "and", "license", "agreement", "for", "ENHANZE\u00ae", "drug", "delivery", "technology", "to", "enable", "development", "of", "\"ultra", "long-acting\"", "medicines", "for", "HIV"], "created_at": "2021-06-22 06:22:00"}
